Future Specialists Speak Out In Support Of Senior Doctors
STONZ executive member, and Obstetrics and Gynaecology trainee Jordan Tewhaiti-Smith says that like the SMOs who are currently striking, 'we are deeply concerned about the safety of our patients and our communities, and the ability for all New Zealanders to access the healthcare we need and deserve'
'As future specialists, we are disappointed in the response from the government so far, and STONZ supports ASMS, and our senior colleagues today.'
'If we want a healthcare system that we can all access and be proud of, we need to ensure that we are valuing our workforce and being clear to everyone that this is important.
'As doctors, we know any decision to strike would not have been taken lightly. We have concerns about the future of specialist care in Aotearoa, New Zealand and an important starting point is to support, value and retain the doctors already working here which we will also be highlighting when we begin negotiations early next year.
'Being a doctor is a job where you can do incredible things. That's why doctors and other health workers put up with so much. We want to help, look after and care for our communities – but there's a point at which many newer doctors will start asking themselves if six years of med school, huge student loans, followed by as many or more years of fatigue, working upwards of 60-70-hour plus weeks and stress pursuing a specialty that they might never get the chance to reach is actually worth it.'
'We, along with our senior colleagues, are advocating for a healthcare system that supports, values and retains our highly trained and skilled clinicians, which can provide better health outcomes for everyone in Aotearoa, New Zealand.'
STONZ is a union for RMOs that is run by RMOs and advocates for the long-term benefit of its members, their patients, and Aotearoa's health system.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scoop
an hour ago
- Scoop
Cancer, Measles And Allergic Disease Research Funded In Latest HRC Grants Round
The Malaghan Institute has been awarded three Health Research Council grants, totalling $7.4M over five years, to improve cancer immunotherapies, protect vulnerable populations from measles outbreaks and investigate new therapeutic targets for eczema. Director Professor Kjesten Wiig says receiving three major grants from the Health Research Council at a time of heightened funding constraints is significant and recognises the calibre and relevance of the Malaghan Institute's science. 'These investments not only reflect confidence in the Malaghan's research across cancer, allergic and infectious diseases, but also the real-world impact of our work on the health of New Zealanders.' Faster CARs: Overcoming exhaustion to enhance cancer immunotherapies Building on the Malaghan Institute's ground-breaking CAR T-cell programme, the Perret team in the Weinkove Laboratory has recieved a $1.2 million project grant over three years to improve on this life-saving treatment. 'In Aotearoa's first CAR T-cell trial, our novel CAR T-cell therapy has shown promising safety and efficacy in people with relapsed lymphomas,' says Dr Rachel Perret. 'However, a known limitation of CAR T-cell therapies is that in some cases, cancers fail to respond, or relapse. This may be due to exhaustion of CAR T-cells during manufacture or inside the patient, due to a immunosuppressive environment around the tumour.' Cells, like people, can become exhausted if overworked or overstimulated, becoming less and less able to perform. However, unlike people, CAR T-cells can be tweaked to block the genes that signal this exhaustion, allowing them to continue fighting cancer for longer – which should also improve patient outcomes. 'This project will re-engineer CAR T-cells to silence genes linked to exhaustion and re-develop CAR T-cell manufacturing processes to enhance CAR T- cell fitness and shorten manufacturing times,' says Dr Perret. 'We expect the results to be applicable to many cancer types, and to be readily translated for the benefit of New Zealanders within our CAR T-cell clinical trial programme.' Providing equal protection for everyone against measles Herd immunity is how we as a population protect those who are immunocompromised or otherwise unable to get vaccinated (such as very young infants) against potentially life-threatening viruses like measles. When enough of the population are vaccinated (over 95% in the case of measles), this herd immunity effectively prevents viruses from spreading to our most vulnerable whānau. 'While the current measles, mumps and rubella (MMR) vaccine is highly effective at protecting vaccinated individuals against these viruses, current vaccination rates are not high enough to provide this essential herd immunity to protect those who cannot be vaccinated,' says paediatric immunologist Dr Kuang Hsiao from Waipapa Taumata Rau, University of Auckland, who is part of the research team. The MMR vaccine cannot be used in people with severely impaired immune systems and is not recommended in pregnant people. Also, MMR is less effective in infants, so is not routinely recommended before 12 months of age. In addition, Māori and Pacific communities are overrepresented among these vulnerable groups. For these populations, alternate protective options are required to prevent a measles outbreak. 'Evidence has shown that mRNA-based vaccines can be effective in these vulnerable individuals,' says the Malaghan's Professor Ian Hermans. 'With an international team involving clinicians, immunologists and Māori and Pacific researchers, we will develop an mRNA-based measles vaccine to give to vulnerable individuals in the event of an outbreak.' The research has been awarded an HRC Programme Grant, worth $5M over five years, and will bring together multiple organisations including the Malaghan, representing diverse areas of expertise and combining both fundamental research and public health. 'As part of this work, we will explore with Māori and Pacific communities' perceptions and beliefs about mRNA-based vaccines to support equitable access to the vaccine,' says Dr Hermans. Investigating novel treatment targets for atopic dermatitis Atopic dermatitis, or eczema, is a chronic skin allergic disease that affects a significant proportion of New Zealand's population. The disease can have a significant negative impact on a person's livelihood with symptoms varying from persistent itchiness, redness, dryness and inflammation. Current treatment options are largely immunosuppressants such as corticosteroids, which can cause side effects. While these treatments can help manage symptoms there are currently no effective therapies to prevent the disease from developing and relapsing. At the cellular level, one hallmark of atopic dermatitis is the chronic infiltration and persistence of immune cells called tissue resident memory T-cells. Normally, these cells are vital for protecting the skin from invading pathogens, but for individuals with atopic dermatitis these cells also contribute to the disease by promoting recurring inflammation even after the allergen has been cleared from the skin. The project, which has been awarded $1.2 million over three years, will be led by Dr Sotaro Ochiai, a Senior Research Fellow in the Ronchese Laboratory. The team will focus on better understanding these tissue resident memory T-cells identifying key genes and biological pathways that are essential for the establishment and maintenance of these cells in the skin. 'By understanding these mechanisms, we aim to identify new therapeutic targets to disrupt tissue resident memory T-cell survival or function and improve quality of life for those affected by this persistent and distressing condition,' says Dr Ochiai.
Otago Daily Times
5 hours ago
- Otago Daily Times
Cancer society services supporting community
The Southern Cancer Society wants to remind the Gore public that engaging with their various Daffodil Day drives funds support and care in the community. Southern Cancer Society manager Gavin Booth said the society gets no funding from the government and relies on donations to fund the role of their important community cancer support worker. Cancer navigator and supportive-care worker Aynsley Dermody's role was funded by donations and, Mr Booth said, her work with those with cancer across Southland was invaluable. "She's like gold," he said. Gore Daffodil Day co-ordinator Sandy Smith said fundraising drives would include auctions, charity game nights and raffles. ANZ Bank was set to hold a silent auction for a painting by Southland artist Julie Duncan and a raffle for a stay in Wānaka. The Gore Daffodil Day team also had its own auction online with a Real Journeys overnight Doubtful Sound cruise on offer. Gore RSA is to hold a Jenga night on Saturday, August 30. Van de Water Jewellers is again having a sales window, with proceeds going to the special day, Mrs Smith said. Cafe Ambience will have a raffle for a cake made by artful baker Jude Taylor of Taylormade Cakes. Mrs Smith said Gore schools were doing coin trails and dress-up days. Her own workplace, Mataura Valley Milk, was having a burger lunch on August 21 for her fellow staff to contribute on their break. Mrs Dermody said she covered the Southern, Eastern, and Northern Southland regions as well as West Otago. With 26 years practising as a registered nurse in hospital and hospice care, she used her experience to support people and their families. "From the time they receive their diagnosis, through treatment and beyond." The Southern Cancer Society assisted with travel and accommodation for treatment. It also assisted with other tasks and connected people with other support services such as counselling, home help, financial support and more. She ran a monthly support group in Gore for those affected by cancer and their families. She also provided help navigating the health system and an individual's treatment and health plan. Being diagnosed with cancer could be one of the most difficult situations a person and their family could ever face in their lifetime, Mrs Dermody said. Their services were free, confidential and she had the time to listen. She was available to make sure people with cancer in the area were well informed, have their questions answered and the level of support they need. "No-one should ever face cancer alone." • If you require cancer support, you can self refer by contacting Aynsley Dermody direct on 0272184008 or 03 2184108 or email at The website for the auction is
NZ Herald
7 hours ago
- NZ Herald
Tairāwhiti among worst regions for heart failure and care, Health NZ working to improve service
A cardiac catheterisation procedure within three days of arrival at the hospital was performed 28.5% of the time in Tairāwhiti compared to the national average of 64.7%. One positive statistic in the report for Tairāwhiti was that the rate at which first medical contact occurred within 60 minutes of having heart attack symptoms was 80% in Tairāwhiti, compared to a national average of 50.2%. The report drew on Ministry of Health data, which indicated there were no cardiologists in Tairāwhiti. The report also notes the Medical Council Workforce Survey showed Tairāwhiti had 0.4 of a fulltime equivalent cardiologist for the entire region. Overall, the report found the country's heart care system was 'on the verge of collapse'. Māori and Pacific people were hospitalised or died from heart disease more than a decade earlier, on average, than other New Zealanders. The national heart health care system was plagued by chronic under-resourcing, critical workforce shortages and deadly inequities. Heart disease contributed to 5% of hospital admissions and 20% of deaths across the country. Health NZ Tairāwhiti group director of operations, Nicola Barrington, told the Gisborne Herald Health NZ was committed to ensuring patients had timely access to high-quality cardiac services wherever they lived in New Zealand. 'We are working hard to improve heart care services in Tairāwhiti by expanding access to cardiology services through a combination of digital health services, visiting specialists – including locum cardiologists and visiting clinicians – and nurse practitioner support," Barrington said. Health NZ had partnered with HeartLab to reduce wait times for heart scan reporting, she said. Barrington said efforts to recruit cardiology specialists to Tairāwhiti had been ongoing for some time. 'As with many other regions in New Zealand, attracting specialists to rural and regional areas like Tairāwhiti remains a challenge,' she said. 'We are continuing to recruit cardiologists, cardiac care specialists and sonographers to Gisborne Hospital. 'These efforts include a dedicated international recruitment campaign promoting the unique lifestyle and professional opportunities that Tairāwhiti offers. 'Encouragingly, we have received applications from a number of experienced doctors, some of whom we hope will focus their careers on caring for our whānau with cardiac issues in Tairāwhiti.' Barrington said Health New Zealand was funding the training of 26 cardiac sonographers, with 10 graduating by the end of this year and the rest next year. The intention was to place them in the areas of greatest need, 'which includes our region'. Health New Zealand's National Clinical Cardiac Network was developing national standards and models of care, and establishing dedicated work streams, with strong clinical leadership and input from many regions, including Tairāwhiti. 'We are also exploring new ways of working within our region to optimise how we share the cardiology expertise to Tairāwhiti to provide equitable care across Te Manawa Taki [the Tairāwhiti, Waikato, Lakes, Bay of Plenty and Taranaki health districts]'. She said the regional approach meant Tairāwhiti could offer better care and have more options for hiring skilled staff. 'We are planning by looking at ways to make our heart care team more resilient, by continuing to recruit nurse practitioners and specialist nurses. 'Our goal is to build a reliable, patient-focused heart service that meets the needs of people in Tairāwhiti now and in the years ahead,' said Barrington.
